Skip to main content
Clinical Trials/CTRI/2022/07/043826
CTRI/2022/07/043826Not yet recruitingPhase 3

Assessment of efficacy of Kinshuktwagadi Gutika in Madhumeha in comparison with Metformin With Special Reference to Type 2 Diabetes Mellitus - A Randomised controlled clinical trial

Dr Priyanka Manohar Babar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Recently diagnosed patients of Type 2 DM.
  • Post Covid-19 patients with newly diagnosed Type 2 DM.
  • Patients irrespective of gender will be included & who are willing to take medicine.
  • Age group within 30-80 yrs.
  • Patients with fasting blood sugar level more than 126 mg/dl and post prandial upto 350mg/dl.
  • Patients with HbA1c value more than 6.5%
  • Patients having signs and symptoms of Madhumeha

Exclusion Criteria

  • K/C/O Type 1 diabetes mellitus.
  • Gestational diabetes.
  • K/C/O BPH, ketoacidosis, Diabetic coma, acute infections anywhere in the body and Gangrene.
  • Patients on insulin and steroid therapy.
  • Patients with any major systemic diseases like Carcinoma, Tuberculosis etc.
  • K/C/O Immunocompromised patients or patients on immunosuppressive drugs.
  • K/C/O â?? Neuropathic ulcer, Peripheral Vascular Disease.

Investigators

Sponsor
Dr Priyanka Manohar Babar

Similar Trials